India’s First Autogenous Solution
Ferric Carboxymaltose Injection 50 mg/ml (2 ml & 10 ml vial)
India’s First Autogenous Solution
Ferric Carboxymaltose Injection 50 mg/ml (2 ml & 10 ml vial)
Darbepoetin Alfa injection 25mcg/40mcg
Mecobalamin, Pyrodoxine Hydrochloride, Folic Acid & Niacinamide Injection
Tri sodium citrate catheter locking solution 46.7%
Iron Sucrose Injection USP 20mg/ml (1 Ampoule of 5 ml)
Calcitriol Injection 1 mcg / ml (1 ml of Ampoule)
Levocarnitine Inj. 200 mg / ml (5 ml Amp)
Recombinant Human Erythropoietin Alfa Injection 2000 IU, 4000IU,6000 IU & 10000 IU
La Renon Healthcare’s journey began in 2007 with the chronic therapeutic segment of Nephrology. We were the first company to foray into this domain with a focus on early stage Chronic Kidney Disease (CKD) Patients. It was a daunting task to begin with especially in a country like India, where at least 6 crore individuals have been suspected to be suffering from some form of Kidney Disease and of which only 1% (6-7 lakhs) are being diagnosed or might be under some form of renal therapy. However, within a short span of time, La Renon has established itself as a leader in the field of Nephrology and serves the highest number of Chronic Kidney Disease (CKD) patients in India today.